CHICAGO--(BUSINESS WIRE)--Shore Capital Partners (“Shore” or “Shore Capital”), a private equity firm focused on microcap investing, today announced several team promotions and new hires, including the appointment of Justin Bentley as Partner and Head of Capital Markets, Brian Tracy as Head of Investor Relations, and Sarah Gabriel as Chief People Officer.

“With the closing of our second Food & Beverage Fund earlier this year, our committed capital base has tripled since 2019 and our portfolio has roughly doubled. To best support our portfolio companies, our team has also tripled over that time frame,” said Justin Ishbia, Managing Partner of Shore. “We believe the next 10 years in the private equity industry will be focused on operations and we are committed to providing outsized resources to our companies, supporting them to grow faster with less risk. Over half our firm is now dedicated to operations. With the most recent promotions and additions to our team, we are providing both continuity and introducing new talent. This helps us be a better partner to our investor base, more effectively manage capital markets, and provide unparalleled operational support to our portfolio companies.”

Justin Bentley has been with the firm since December 2020 and has been promoted to Partner and Head of Capital Markets. He is responsible for leading the firm’s capital markets efforts, including the financing activities of all new investments and portfolio companies, as well as developing and managing Shore’s banking and intermediary relationships.

Brian Tracy joins Shore as Head of Investor Relations, responsible for leading the firm’s capital raising and investor relations efforts. He brings over 20 years of experience in investor relations and institutional sales, most recently serving as Head of Investor Relations, Private Funds at Burford Capital. Prior to Burford, Mr. Tracy held senior positions in investor relations at Brookfield Asset Management and Wolverine Asset Management.

In addition, Sarah Gabriel joins the firm as Chief People Officer, where she leads strategy for people operations and development, and supports portfolio company management teams by providing human resources expertise and shared learnings. Ms. Gabriel has 20 years of experience in private equity and most recently served as a partner at Kirkland & Ellis and co-led the Center of Excellence for the Public Company Advisory Practice. Prior to Kirkland & Ellis, Ms. Gabriel held executive leadership positions in public and private companies, including roles as a Chief Compliance Officer and General Counsel.

In addition, the firm congratulates the following individuals on their promotions within the Shore Resource Team: Chase Hall (Senior Director), Joe Pizetoski (Director), Shannon Finocchi (Director), Brandon Coan (Director) and Peter Roehmholdt (Director). Shore also welcomes Sean McDonald (Continuous Improvement Director), Johnny Mishu (Marketing Director) and Kelley Harrington (Payor Consulting Director) to the Resource Team’s Centers of Excellence.

About Shore Capital Partners

Shore Capital Partners, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com.

Contacts

Shore Capital Partners
Jordan Niezelski, Edelman Smithfield
jordan.niezelski@edelmansmithfield.com

‍

CHICAGO--(BUSINESS WIRE)--Shore Capital Partners, (“Shore” or “Shore Capital”), a strategic private equity firm focused on microcap investing in the healthcare, food and beverage, and business services industries, with offices in Chicago and Nashville, has been named one of Inc.’s Founder-Friendly Investors for the third year in a row. Inc.’s annual list recognizes private equity and venture capital firms that entrepreneurs collaborate with and trust as they receive the financial support needed to help drive growth. All firms named to the list have successful track records of remaining actively involved with the businesses they invest in.

“We take great pride in being named to Inc.’s Founder-Friendly Investors list for the third year in a row,” said Justin Ishbia, founder and Managing Partner of Shore. “Our vision is to be the first choice of entrepreneurs seeking a growth partner and this recognition is a testament to the years of hard work and strategy to help founders grow into regional and national powerhouses. We believe the next ten years of private equity is all about operations and our team is designed to help great small and medium companies grow bigger, stronger, and faster with less risk.”

A unique offering within the microcap market, Shore’s dedicated team of over thirty operating professionals as of the release date, provide resources to portfolio companies to de-risk decision making and accelerate growth. The scale of this team is traditionally accessible only to mid- and large-cap companies. In addition to direct support of individual companies, the resource team promotes collaboration between leaders across the portfolio, organizes networking and development events, and meets regularly to share experiences and collaborate on common challenges operators face today.

“Fully investing in an entrepreneur, and their innovative vision, involves far more than the financial investment. By developing relationships with and supporting entrepreneurs for the long-term, these private equity firms are more than investors, they’re partners,” added Scott Omelianuk, editor-in-chief of Inc.

To compile the list, Inc. went straight to the source: entrepreneurs who have sold to private equity and venture capital firms. Founders filled out a questionnaire about their experiences partnering with private equity and venture capital firms and shared data on how their portfolio companies have grown during these partnerships.

To see the complete list, go to: https://www.inc.com/founder-friendly-investors/2022. The October 2022 issue of Inc. magazine is available online at https://www.inc.com/magazine and on newsstands now.

About Shore Capital Partners

Shore Capital Partners, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com.

About Inc.

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community they need to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com.

Contacts

Shore Capital Partners
Jordan Niezelski, Edelman Smithfield
jordan.niezelski@edelmansmithfield.com

‍

CHICAGO--(PE HUB)--When Shore Capital Partners sold EyeSouth Partners to Olympus Partners, the sale was the culmination of a five year buy-and-build strategy that grew the regional ophthalmology services manager 20-fold from 13 practitioners to 270. The deal, which was announced in September, was valued at just under $1 billion and grew WBITDA from $2 million to more than $70 million, according to sources familiar with the transaction.

PE Hub interviewed Shore Capital partner Chris Mioton to get an inside look at what levers were pulled to grow and scale the asset, as well as how the dealmaking process evolved during a volatile economic environment.

EyeSouth was formed by Chicago-based Shore Capital back in 2017 with an initial investment in Georgia Eye Partners, a leading ophthalmology practice based in Atlanta with 13 doctors and five locations. This was shortly followed by an investment in Georgia Retina, another practice in Atlanta with a "sterling reputation," according to Mioton.

“With that foundation, the team built EyeSouth into what it is today – over 270 doctors and 155 locations in 11 states,” he explained. EyeSouth was a “great case study of execution across both organic and inorganic growth levers.”

“Organically, EyeSouth doubled market growth rates through the execution of our management team in recruiting new physicians, developing and utilizing new service lines (such as premium cataract offerings), and building de novo clinic and surgery center locations,” said Mioton. “The EyeSouth team, with the support of Shore Capital, also affiliated with and integrated 33 practices throughout our ownership.”

As with any deal, this transaction required “significant negotiating from both parties at the end,” Mioton explained. “With financing markets in their current state, I could understand why there may be a more significant price gap in certain cases, but that was not an impasse for this process in particular.”

The plans were to sell in 2022 and it was a “fairly standard auction process,” and it went through multiple rounds of bids.

He also noted that given the firm’s investment focus on the lower-mid-market, and starting with relatively conservative leverage at entry, Shore Capital “has been fortunate to elude some of the negative consequences of these conditions on the new investment side.”

“On the sell-side, we expect that premium assets will continue to command a premium, even in a turbulent market,” he said. “We are focused on equipping our companies with the best people and resources to navigate the specific challenges each of them face, and our goal is for each to be viewed as best-in-class in their respective industries.”

When asked how the firm is able to execute on these deals, with plenty of market-related reasons why buyers could say no, Mioton said “our goal is to build companies supported by experienced management teams and with sustainable growth levers to demonstrate a path to a strong return for the next buyer and an enterprise that is built to last. Companies with those characteristics sell themselves, even in a challenged macro environment.”

He added that Shore Capital’s returns “have continued to remain strong.”

“The majority of our value creation comes through replicable growth levers,” he said. “For larger players where debt availability and cash generation drives a more significant portion of their return, I would imagine the impact to returns is more acute.”

CHICAGO--(BUSINESS WIRE)--Shore Capital Partners (“Shore” or “Shore Capital”), a Chicago-based private equity firm focused on microcap investments within the Healthcare, Food and Beverage, and Business Services industries, is pleased to announce the sale of IZI Medical Products (“IZI”), its interventional radiology medical device portfolio company, to Halma plc (“Halma”), a global group of life-saving technology companies focused on growing a safer, cleaner and healthier future for everyone, every day.

Shore Capital partnered with IZI in 2016 with the goal of building a leading innovator, manufacturer and distributor of quality medical devices. Led by Chief Executive Officer Greg Groenke, the team at IZI has built a diverse portfolio of consumable devices used in interventional radiology and oncology, radiation therapy, neuro-spine and image guided surgery procedures. IZI’s products and technologies are employed in approximately 2,000 domestic hospitals, as well as utilized internationally across 35 countries.

“Shore Capital is proud to have partnered with Greg and the IZI team to build the company into one of the leading medical device platforms in the interventional market,” said Don Pierce, Partner at Shore Capital and Chairman of the Board at IZI. “IZI is well positioned to continue growing as a leader in the industry. We appreciate the contribution of all employees and wish the team success as they embark on this next chapter with an excellent partner in Halma.”

“Shore Capital was a true partner that shared our vision for growth and success, providing more than just capital during our partnership. The firm supported with investing in our people, developing our technology and growing our business through strategic acquisitions,” said Groenke. “Our mission is to improve patients’ lives with physician-led innovation, which aligns with Halma’s vision to improve the quality of care delivered by healthcare providers. Joining the Halma group will take IZI to the next level, adding research and development capabilities and bringing international growth opportunities that will support our journey to advance healthcare for patients worldwide.”

The transaction closed on September 30, 2022. Winston & Strawn LLP served as legal advisor to Shore Capital and IZI on the transaction.

About Shore Capital Partners

Shore Capital, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com.

About IZI Medical Products

As a leading innovator, manufacturer, and distributor of quality medical devices, IZI Medical provides the continuity that our healthcare partners need to succeed. Based in Owings Mills, Maryland, just outside Baltimore, IZI is a leading developer, manufacturer, and provider of high-quality medical consumable devices used in radiology, radiation therapy, neuro-spine, and image guided surgery procedures. IZI has built a diverse portfolio of products backed by strong intellectual property and currently sells to more than 2,000 domestic customers as well as internationally across 35 countries. For more information, please visit www.izimed.com.

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad market areas where it operates: safety, the environment and healthcare. Halma employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index. For more information, please visit www.halma.com.

Contacts

Shore Capital Partners
Allison Dorr, Edelman Smithfield
allison.dorr@edelmansmithfield.com

‍

CHICAGO--(BUSINESS WIRE)--Shore Capital Partners (“Shore” or “Shore Capital”), a Chicago-based private equity firm focused on microcap investing, is pleased to announce the sale of EyeSouth Partners (“EyeSouth”), an eye care management services organization committed to partnering with leading doctors, to Olympus Partners.

Shore formed EyeSouth in 2017 with the goal of creating a leading ophthalmology platform in the South and providing the highest level of support to its practices and clinicians. At the time of founding, Shore completed a strategic partnership with Georgia Eye Partners and its founding physician, Dr. Eugene Gabianelli, was appointed Chief Medical Officer of EyeSouth. Led by Chief Executive Officer Rex Adams, EyeSouth has grown its affiliate network from 5 locations to over 155 locations throughout Georgia, Texas, Louisiana, Florida, Tennessee, Ohio, Kentucky, Pennsylvania, Alabama, North Carolina and Illinois.

“We are extremely proud of what the EyeSouth team has built,” said Justin Ishbia, Chairman of the EyeSouth Board and Founder and Managing Partner of Shore. “Through the company’s significant growth, the EyeSouth team remained committed to clinical quality and a patient-first culture above all else. With strong executive management in place under Rex’s leadership, we look forward to following EyeSouth’s continued growth as a leading national eye care provider.”

“EyeSouth’s doctor ownership model and industry-leading support services have enabled the company to rapidly expand from 12 doctors at founding to over 270 doctors currently,” said Chris Mioton, Member of the EyeSouth Board and Partner at Shore. “EyeSouth recently entered Illinois, its 11th state, and has experienced incredible momentum since the company’s creation five years ago. We wish the EyeSouth team continued success in their next chapter with Olympus.”

“Shore’s partnership was invaluable and enabled us to expand rapidly,” said Adams. “We were able to move faster with less risk, given Shore’s years of experience investing in healthcare businesses and deep bench of hands-on operational support typically only accessible to large-cap companies.”

“Since starting Georgia Eye Partners in 1999, our primary focus has been providing top-quality clinical care, and I am delighted that we have maintained this since expanding and adding new affiliates to the EyeSouth platform,” said Dr. Gabianelli. “We look forward to continuing to support physicians with resources that enable them to do their best work and provide exceptional care to their patients.”

Rich Agabs, Atishay Chopra and Brian Castiglioni of Jefferies LLC are serving as exclusive financial advisor through their Essential Outpatient Healthcare franchise and Winston & Strawn LLP is serving as legal advisor to Shore and EyeSouth. Bass, Berry & Sims is serving as regulatory counsel to Shore and EyeSouth.

About Shore Capital Partners

Shore Capital Partners, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services and Real Estate industries. Shore supports management partners with capital, business development expertise and industry knowledge to accelerate growth, fund acquisitions and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com.

About EyeSouth Partners

Headquartered in Atlanta, Georgia, EyeSouth Partners is an eye care management services organization committed to partnering with leading physicians to build a premier network of eye care services throughout the U.S. EyeSouth’s partner practices’ clinical mission is to provide high quality medical and surgical specialty eye care. EyeSouth supports its affiliated practices and physician partners with strategic guidance, administrative resources, operating expertise and capital with an absolute focus on clinical quality and a patient-first culture. EyeSouth’s affiliate network consists of over 270 doctors providing medical and surgical eye care services at over 155 locations throughout Georgia, Texas, Louisiana, Florida, Tennessee, Ohio, Kentucky, Pennsylvania, Alabama, North Carolina and Illinois. For more information about EyeSouth Partners, please visit: www.eyesouthpartners.com.

Contact

Shore Capital Partners
Allison Dorr, Edelman Smithfield
allison.dorr@edelmansmithfield.com

‍

CHICAGO--(BUSINESS WIRE)--Shore Capital Partners (“Shore” or “Shore Capital”) is pleased to announce it has formed a partnership with Moesle Meat Distribution Co. (“Moesle” or the “Company”), a wholesale meat distributor supplying beef, poultry, pork, seafood and other protein products to grocery retail, foodservice, and redistribution customers in the Midwest.

Moesle was founded in the 1940s and recently expanded into a new Class A distribution facility in southwest Chicago that has allowed the business to continue to scale and serve a diverse range of grocery and foodservice customers from independent stores to larger chains (20+ locations) with ordering and delivery, storage, and processing capabilities. In addition to the operations in Chicago, the Company has a facility location in Kansas City, KS, doing business as Queen Foods, primarily serving independent restaurants and grocery customers in Kansas and Missouri. Shore Capital is partnering with the Company’s CEO, Joel Janecek, and his team which has led Moesle through tremendous growth over the past five years.

“Our partnership with Shore Capital will allow us to accelerate our organic growth through new customer acquisition, product and category expansion, and exploring opportunities to support our current and future customers with value-added processing capabilities,” said Janecek. “We are confident that Shore’s playbook and resources will help us take Moesle to the next level, as we look to build on our existing business while also exploring add-on partnership opportunities with other distribution and processing companies in the Midwest.”

Moesle and Shore plan to invest in business development, sales & marketing, purchasing, technology systems, and warehouse and distribution infrastructure to further enhance operations and explore new growth avenues. Together, Moesle and Shore will also pursue inorganic growth opportunities through add-on acquisition partnerships to expand geographic coverage, category depth, and channel and format capabilities.

“We could not be more excited to partner with the entire Moesle team and look forward to establishing a leading specialty distribution and processing platform in the Midwest and beyond,” said Richard Boos, Partner at Shore and Chairman of Moesle Meat Distribution. “Joel and his team have built an impressive organization focused on delivering excellent customer service and a commitment to continuous improvement and high quality.”

“Shore has been studying the specialty food distribution industry for several years and we are confident we have found the ideal starting point to build a regional platform. We will work hard to collaborate with Joel and the entire Moesle team to build on their success while maintaining the unique culture that has enabled the business to reach this milestone,” added Jeff Smart, Principal at Shore Capital.

About Shore Capital Partners

Shore Capital, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com.

About Moesle Meat Distribution

Moesle Meat Distribution is a specialty food distributor focused on providing beef, poultry, pork and seafood to the independent grocery retail, redistribution and foodservice channels in the Chicagoland area, Indiana, Wisconsin, Minnesota, Missouri, Kansas and Kentucky. The Company is headquartered in Chicago, IL and has a facility in Kansas City, KS doing business as Queen Foods. For more information, please visit: https://moeslemeats.com/.

Contacts

Shore Capital Partners
Jordan Niezelski, Edelman
jordan.niezelski@edelman.com

Moesle Meat Distribution
Joel Janecek
joel@moeslemeats.com

‍

CHICAGO--(BUSINESS WIRE)--Shore Capital Partners (“Shore” or “Shore Capital”) is pleased to announce it has completed a partnership with AA Medical, a provider of sustainable solutions to both the new and resale medical device equipment markets based in Mokena, Illinois, with a second location in Miami, Florida.

AA Medical was founded in 2012 by Ron Plantz to help doctors and surgeons across the world access high quality pre-owned medical equipment at an affordable price. AA Medical partners with equipment manufacturers, banks, and medical facilities to buy pre-owned equipment, unlocking the residual value to help facilities maximize resources to improve patient care and optimize clinical asset purchases.

AA Medical works with physicians in over 100 countries and has grown into one of the largest and most respected aftermarket equipment companies in endoscopy, orthopedics and other specialties. A key factor in its success is the management team’s dedication to their customer and partner experience through strategic investments in technology, sales, and marketing tools. The management team at AA Medical has over 50 years of combined experience in the medical device industry, led by President Mr. Plantz and CEO Matt Nelson.

“We are excited to announce our partnership with Shore Capital and utilize their expertise working with businesses of our size, wide network, and extensive resources to expedite our next phase of growth,” said Mr. Plantz. “In conjunction with Shore, Matt and I look forward to continuing to provide excellent service and products to our customers.”

To support AA Medical’s growth, Shore has assembled a talented Board of Directors led by Don Pierce, Partner at Shore Capital. “Shore is proud to partner with Ron, Matt, and the entire AA Medical family. AA Medical has maintained their dedication to excellence in supplying high quality medical equipment to customers across the world,” said Mr. Pierce. “We are well-positioned to build on AA Medical’s reputation as an industry leader through both acquisitions and organic growth.”

AA Medical and Shore believe there is an opportunity to build a strong and diversified medical reprocessing company together through new industry partnerships, business development and further investment in the Company’s products and team.

“I have high confidence that, with Shore, we can continue to revolutionize the third-party medical equipment market,” said Mr. Nelson. “We are excited to work together to further our vision of increasing worldwide access to affordable, high-quality healthcare.”

About Shore Capital Partners

Shore Capital, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com.

About AA Medical

AA Medical has provided sustainable solutions to both the new and resale medical equipment markets since 2012, with a concentration in endoscopic, orthopedic, and other surgical devices. As a critical partner in cost containment, AA Medical helps medical facilities unlock residual value from unneeded equipment while providing reprocessed equipment that otherwise would be prohibitively expensive to purchase new to small, rural, specialty, and international medical facilities. For more information, please visit www.aamedicalstore.com.

Contacts

Shore Capital Partners
Jordan Niezelski, Edelman
jordan.niezelski@edelman.com

‍

CHICAGO & CHINO, Calif.--(BUSINESS WIRE)--Shore Capital Partners (“Shore” or “Shore Capital”) is pleased to announce it has formed a growth partnership with OC Flavors (“OC” or the “Company”), a custom flavor developer and manufacturer based in Chino, California.

OC Flavors was founded in 2007 by Leah McCuen and Monica Ahuero to offer a full range of natural and organic flavors and flavoring solutions across a variety of food, beverage and supplement product applications. Operating out of a BRC-certified production facility and innovation center, the Company’s core offerings include liquid and powdered flavors for the beverage, dairy, plant-based, nutraceutical, snacking, confection and bakery industries. Shore Capital is partnering with the Company’s management team, which has led OC Flavors through tremendous growth over the past 15 years.

“We are thrilled to partner with Shore given their strategic approach and track record for building businesses like ours,” McCuen said. Ahuero added, “We are confident that Shore’s playbook and resources will help us take OC to the next level, as we look to maintain our winning culture while providing our customers and industry partners with world-class quality, service and innovation.”

OC and Shore plan to invest in several key initiatives to drive growth, including added support in key areas such as sales and marketing, research and development, and operational infrastructure. Together, OC Flavors and Shore will explore opportunities for inorganic growth through acquisitions and organic growth through new products and service offerings to deepen OC’s value proposition and customer relationships.

“We are honored to partner with the OC Flavors team on this next exciting chapter in the Company’s impressive history,” said Richard Boos, Partner at Shore and Chairman of OC Flavors. “Leah and Monica have built tremendous reputations in the flavor industry and a world-class organization with values and priorities that align extremely well with Shore’s. We could not be more excited to start executing our growth plan with the OC Flavors team.”

“Shore has been studying the flavors industry for several years, and we are confident we have found the perfect entrepreneurs and team to partner with at OC Flavors,” said Jeff Smith, Principal at Shore Capital. “We see tremendous opportunity for the Company moving forward as we add resources and capabilities to further enhance our offerings for our customers. We also look forward to welcoming additional flavor and related specialty ingredient companies into the family as we complete strategic add-on acquisitions.”

About Shore Capital Partners

Shore Capital, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com.

About OC Flavors

Since 2007, OC Flavors has provided custom flavors and flavoring solutions to help food and beverage creators navigate the complexities of their industries and develop flavors that set their products apart. Since its founding, the Company has built deep customer relationships and an excellent industry reputation by providing quality, innovative flavors with a particular emphasis on natural and organic-certified offerings. Today OC Flavors is a leading supplier and innovator for flavors across the beverage, snack bar, bakery, nutraceutical, dairy and plant-based categories, among other applications. For more information, please visit: www.ocflavors.com.

Contacts

Shore Capital Partners
Jordan Niezelski, Edelman
jordan.niezelski@edelman.com

OC Flavors
Leah McCuen
leah@ocflavors.com

Monica Ahuero
monica@ocflavors.com

‍

CHICAGO & ATLANTA--(BUSINESS WIRE)--Shore Capital Partners (“Shore Capital” or “Shore”) is pleased to announce that it has founded OMS360 with the completion of strategic partnerships with Kentucky Center for Oral and Maxillofacial Surgery (“KCOMS”) and Community Oral Facial Surgery (“COFS”). Together, OMS360 (“The Company”) consists of seven oral and maxillofacial surgery practices located across Kentucky, Alabama and Georgia.

OMS360 is an oral surgeon support organization that partners with quality practices to deliver expertise in business development, finance, marketing, recruiting, benefits and other practice administration while enhancing oral surgeons’ ability to provide the highest quality of patient care. The Company has developed an impressive executive and operational support team based in Atlanta, Georgia. OMS360 is led by Chief Executive Officer Trevor Maurer, who is an experienced healthcare executive with a background in scaling and managing multi-site healthcare businesses. OMS360 continues to build its network of practices with expectations of becoming a preeminent oral surgeon support organization throughout the South and Mid-Atlantic regions of the United States.

Shore Capital is excited to partner with Drs. Bob Clark, Donald Max and Jason Ford from KCOMS, as well as Drs. Josh Everts, Ryan Livingston, Fred Atwell and David Davis from COFS, as they are some of the leading oral surgeons in Kentucky, Alabama and Georgia. The doctors have distinguished themselves as leaders by demonstrating a strong commitment to clinical quality and a patient-centric approach to care within their local communities. Further, these doctors have remained influential and involved with various oral surgery-related industry organizations that are critical to upholding the highest standards of patient care on both a local and national scale. Drs. Bob Clark and Josh Everts will join the Board of Directors for OMS360 and play an important role in further developing the growth strategy and optimizing the service offering to enhance operations at each affiliated practice.

Chris Mioton, Partner at Shore Capital, said, “We could not be more excited to partner with the doctors and team members at KCOMS and COFS. Both of these practices are leaders in their respective communities. Through Shore Capital’s extensive experience investing in medical practices, we share the founding doctors’ commitment to quality medicine and taking a patient-centric approach to lay the foundation for success. We are eager to partner with additional oral surgeons who embrace that philosophy.”

Mioton added, “We initially got to know Trevor as an operating partner over the last several years, including in his role as a Board member at Southern Orthodontic Partners, another Shore portfolio company. We are thrilled to expand our relationship with Trevor as CEO of OMS360 and support the talented management team he is assembling.”

Dr. Clark said, “We are proud of the practice we have built and appreciate the trust our patients and referral partners place in us. We believe Shore Capital and OMS360 represent the ideal partner to help facilitate our next phase of transformational growth and share our commitment to clinical quality and maintaining the best possible culture and experience for our employees and patients. I look forward to working closely with this industry-leading management team and executing on our shared vision to enhance practice operations and expand the delivery of quality patient care to each community we serve.”

Dr. Everts added, “Shore’s track record in the healthcare delivery arena is top of its class and the depth of their expansive internal resource team was something we didn’t find with other organizations. The capabilities of OMS360 will provide us access to operating expertise, strategic guidance, capital and administrative resources to help our practice continue its ambitious growth trajectory throughout Alabama and Georgia.” He continued, “I am eager to build upon OMS360’s excellent clinical reputation and expand the geographical reach through partnerships with other industry-leading oral surgeons.”

“Building a best-in-class oral surgeon support organization requires a strong foundation of surgeons and business leaders, a commitment to clinical excellence and a customized approach to the operations of each practice affiliate. The doctors and team members of KCOMS and COFS represent the ideal practices to join the OMS360 network. Their proven track record of practice growth, outstanding clinical reputation and commitment to their local communities are truly unique,” said Maurer. “We are well-positioned to grow and support our oral surgery practice partners as the healthcare industry transitions to a more consumer-oriented care model. While we must provide convenient and affordable care, we believe the oral surgeons’ role is invaluable and clinical expertise will be the most critical aspect of treatment. Additionally, Shore has helped to bring together an exceptional board of directors consisting of industry thought leaders and doctors alike to guide our strategy and growth plan.”

Shore Capital and OMS360 continue to invest in people and processes to support the operations, business development, finance, accounting, human resources and information technology functions at their affiliated practices to allow the oral surgeons to focus on clinical excellence and serving their communities. The Company will pursue affiliations with independent oral and maxillofacial surgery practices in order to build a network of top clinicians that maintains an oral surgery-led culture.

OMS360 represents the second platform investment out of Shore Capital Partners Healthcare Fund IV, L.P., a $366 million investment vehicle raised in July 2021.

To learn more about partnerships with OMS360, visit www.oms360.com or contact Zach Burger, Chief Development Officer, zach@oms360.com.

About Shore Capital

Shore Capital, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has raised approximately $2.7 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com.

‍

CHICAGO & RIVERWOODS, Ill.--(BUSINESS WIRE)--Shore Capital Partners (“Shore” or “Shore Capital”) is pleased to announce it has completed a partnership with HowardSimon (the “Company”), a retirement third-party administrator and payroll services provider based in Riverwoods, Illinois.

HowardSimon was founded in 1981 by Howard Simon to provide retirement plan administration services for small- and medium-sized businesses. After its founding, HowardSimon further developed its service and product offerings to include recordkeeping, 3(16) fiduciary services, payroll services and human capital management services, with the goal of integrating retirement and payroll services into a single platform to best serve employers and their employees. Today, HowardSimon has grown into one of the largest and most respected retirement third-party administrators in the Midwest while maintaining exceptional customer service.

“We are thrilled to announce our partnership with Shore Capital given their extensive operating resources, network and track record of performance,” said Howard Simon. “We are proud of our team’s relentless dedication to the customer experience and believe our partnership with Shore will enable HowardSimon to continue providing outstanding service and the highest quality product to our customers over the long term. Brad, Doug, myself and the entire Simon family are looking forward to growing HowardSimon with Shore.”

To support HowardSimon’s growth plan, Shore assembled a diverse and talented Board of Directors led by Brad Morehead, Partner and Head of Business Services Partners Fund at Shore Capital. “We are incredibly excited to partner with the team at HowardSimon and grow together into a leading multi-regional retirement services provider,” said Brad. “The Simon family has built a strong culture and foundation for growth.”

Together, HowardSimon and Shore will explore opportunities for growth through new partnerships and business development and continue to invest in the Company’s products and infrastructure.

“We commend the HowardSimon team for its strategic vision and dedication to outstanding customer service over the past 40 years,” said Mickey Jiang, Principal at Shore Capital. “HowardSimon provides a unique integration of retirement and payroll solutions, and we are confident that through our partnership, we will be able to unlock further opportunities to best serve both existing and future customers.”

About Shore Capital Partners

Shore Capital, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has raised approximately $2.7 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com.

About HowardSimon

HowardSimon has been providing creative financial solutions to clients since 1981. Over the years, the company has grown and evolved into one of the largest and most respected retirement plan administration, payroll, and human capital management providers in the Midwest. Along with being a leader and a resourceful provider of services, HowardSimon offers a truly integrated program that combines retirement plan and payroll information into a single platform, creating a unique employee experience as well as a single source, web-based Human Resources Information System solution. For more information, please visit www.hsimon.com.